Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|May 15, 2002
Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF)M A Batey, J G Wright, A Azzabi, et al.
International Journal of Oncology|July 16, 2004
Chromosomal alterations in breast cancer revealed by multicolour fluorescence in situ hybridizationM B Watson, H Bahia, J N E Ashman, et al.
British Journal of Cancer|February 9, 2006
Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopyD J Manton, A Chaturvedi, A Hubbard, et al.
Cancer Chemotherapy and Pharmacology|March 6, 1998
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumorsB Tranchand, G Catimel, C Lucas, et al.
British Journal of Cancer|March 1, 1995
The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancerM J Lind, L Gumbrell, B M Cantwell, et al.
Cancer Treatment Reviews|January 1, 1993
Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic resultsA H Calvert, M J Lind, M M Millward, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)M J Millward, D R Newell, V Mummaneni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancerM J Millward, D R Newell, K Yuen, et al.
Seminars in Oncology|October 1, 1994
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation studyA H Calvert, M J Lind, S Ghazal-Aswad, et al.
Biochemical Pharmacology|March 29, 1994
Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamideD Walker, J P Flinois, S C Monkman, et al.
Pageof 7